Quality is not optional in the life sciences industry — it is the foundation on which patient safety, regulatory approval, and business survival are built. Whether a company is developing a new drug, manufacturing a medical device, running clinical trials, or producing biologics, every step of the product lifecycle must be documented, controlled, and traceable. This is where Life Sciences...

The global quality management software (QMS) market is experiencing strong expansion as organizations increasingly prioritize regulatory compliance, operational efficiency, product quality, and streamlined quality processes. The market was valued at USD 12.3 billion in 2025 and is estimated to reach USD 13.4 billion in 2026. It is projected to expand to USD 28.8 billion by 2033,...